2.4.1.9 Html 57 186 1 false 24 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.BioPharmX.com/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 00100 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.BioPharmX.com/role/StatementUnauditedCondensedConsolidatedBalanceSheets Unaudited Condensed Consolidated Balance Sheets false false R3.htm 00105 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.BioPharmX.com/role/StatementUnauditedCondensedConsolidatedBalanceSheetsParenthetical Unaudited Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.BioPharmX.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 00300 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.BioPharmX.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows Unaudited Condensed Consolidated Statements of Cash Flows false false R6.htm 10101 - Disclosure - Description Of Business And Summary Of Significant Accounting Policies Sheet http://www.BioPharmX.com/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies Description Of Business And Summary Of Significant Accounting Policies false false R7.htm 10201 - Disclosure - Going Concern Considerations and Management's Plan Sheet http://www.BioPharmX.com/role/DisclosureGoingConcernConsiderationsAndManagementSPlan Going Concern Considerations and Management's Plan false false R8.htm 10301 - Disclosure - Balance Sheet Detail Sheet http://www.BioPharmX.com/role/DisclosureBalanceSheetDetail Balance Sheet Detail false false R9.htm 10401 - Disclosure - Related Party Payables Sheet http://www.BioPharmX.com/role/DisclosureRelatedPartyPayables Related Party Payables false false R10.htm 10501 - Disclosure - Commitments and Contigencies Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigencies Commitments and Contigencies false false R11.htm 10601 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquity Convertible Redeemable Preferred Stock and Stockholders' Equity false false R12.htm 10701 - Disclosure - Stock-Based Compensation Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R13.htm 10801 - Disclosure - Income Taxes Sheet http://www.BioPharmX.com/role/DisclosureIncomeTaxes Income Taxes false false R14.htm 20101 - Disclosure - Description Of Business And Summary Of Significant Accounting Policies (Policies) Sheet http://www.BioPharmX.com/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Description Of Business And Summary Of Significant Accounting Policies (Policies) false false R15.htm 30303 - Disclosure - Balance Sheet Detail (Tables) Sheet http://www.BioPharmX.com/role/DisclosureBalanceSheetDetailTables Balance Sheet Detail (Tables) false false R16.htm 30503 - Disclosure - Commitments and Contigencies (Tables) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesTables Commitments and Contigencies (Tables) false false R17.htm 30603 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Tables) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityTables Convertible Redeemable Preferred Stock and Stockholders' Equity (Tables) false false R18.htm 30703 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R19.htm 40101 - Disclosure - Description Of Business And Summary Of Significant Accounting Policies (Details) Sheet http://www.BioPharmX.com/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails Description Of Business And Summary Of Significant Accounting Policies (Details) false false R20.htm 40201 - Disclosure - Going Concern Considerations and Management's Plan (Details) Sheet http://www.BioPharmX.com/role/DisclosureGoingConcernConsiderationsAndManagementSPlanDetails Going Concern Considerations and Management's Plan (Details) false false R21.htm 40301 - Disclosure - Balance Sheet Detail (Details) Sheet http://www.BioPharmX.com/role/DisclosureBalanceSheetDetailDetails Balance Sheet Detail (Details) false false R22.htm 40501 - Disclosure - Commitments and Contigencies (Details) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails Commitments and Contigencies (Details) false false R23.htm 40502 - Disclosure - Commitments and Contigencies (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails2 Commitments and Contigencies (Details 2) false false R24.htm 40503 - Disclosure - Commitments and Contigencies (Details 3) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails3 Commitments and Contigencies (Details 3) false false R25.htm 40601 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails Convertible Redeemable Preferred Stock and Stockholders' Equity (Details) false false R26.htm 40602 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails2 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 2) false false R27.htm 40603 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 3) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails3 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 3) false false R28.htm 40604 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 4) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails4 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 4) false false R29.htm 40701 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) false false R30.htm 40702 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationDetails2 Stock-Based Compensation (Details 2) false false R31.htm 40801 - Disclosure - Income Taxes (Details) Sheet http://www.BioPharmX.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 had a mix of decimals attribute values: 0 2. Element us-gaap_FairValueAdjustmentOfWarrants had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromWarrantExercises had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '40201 - Disclosure - Going Concern Considerations and Management's Plan (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40701 - Disclosure - Stock-Based Compensation (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Unaudited Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Apr. 30, 2014' Process Flow-Through: Removing column 'Jan. 31, 2014' Process Flow-Through: 00105 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: 00300 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows bpmx-20150430.xml bpmx-20150430.xsd bpmx-20150430_cal.xml bpmx-20150430_def.xml bpmx-20150430_lab.xml bpmx-20150430_pre.xml true true